Secretory <scp>IgA</scp> Is a Key Marker Among Gut Barrier Dysfunction‐Related Immunoglobulins Predicting Outcomes in <scp>ACLF</scp>
Boglárka Balogh(University of Debrecen), Mária Papp(University of Debrecen), Dávid Tornai(Beth Israel Deaconess Medical Center), Patrícia Kováts(University of Debrecen), Minneke J. Coenraad(Leiden University Medical Center), Wim Laleman(University Hospital Münster), Péter Antal‐Szalmás(University of Debrecen), Anikó Csillag(University of Debrecen), Zsuzsanna Vitális(Semmelweis University), Tamás Dinya(University of Debrecen), István Tornai(University of Debrecen), Jonel Trebicka(Klinik für Schlafmedizin)
Cited by 4
Related Papers
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
|Hepatology|2013|257
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
|Critical Care|2006|249